Sample preparation prior to the LC-MS-based metabolomics/metabonomics of blood-derived samples

Bioanalysis

Volumn 3, Issue 14, 2011, Pages 1647-1661

  Gika, Helen ^a   Theodoridis, Georgios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BIOMEDICINE; BLOOD SAMPLING; CAPILLARY ELECTROPHORESIS; COMPARATIVE STUDY; ENZYME MECHANISM; ERYTHROCYTE; GENE EXPRESSION PROFILING; HUMAN; INCUBATION TIME; IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; METHODOLOGY; NONHUMAN; PRECIPITATION; QUALITY CONTROL; REVIEW; TURBULENT FLOW; UPREGULATION;

ANIMALS; CHROMATOGRAPHY, LIQUID; HUMANS; METABOLOMICS; TANDEM MASS SPECTROMETRY;

EID: 79960540465     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.11.122     Document Type: Review

References (59)

1. Nicholson JK, Connelly J, Lindon JC, Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nature Rev. Drug Discov. 1(2), 153-161 (2002). (Pubitemid 41646523)
2. Nicholson JK, Lindon JC. Systems biology: metabonomics. Nature 455(7216), 1054-1056 (2008).
3. Theodoridis GA, Gika H, Wilson ID. Mass spectrometry-based holistic analytical approaches for metabolite profiling in systems biology studies. Mass Spectrometry Rev. DOI: 10.1002/Mas.20306 (2011) (Epub ahead of print
4. Lenz EM, Wilson ID. Analytical strategies in metabonomics. J. Proteome Res. 6(2), 443-458 (2007 (Pubitemid 46340149)
5. Wilson ID, Nicholson J. Metabonomics and global systems biology. In: Metabolomics, Metabonomics and Metabolite Profiling. RSC, Cambridge, UK. 295-316 (2007).
6. Theodoridis G, Gika HG, Wilson ID. LC-MS-based methodology for global metabolite profiling in metabonomics/ metabolomics. Trends Analyt. Chem. 27(3), 251-260 (2008).
7. Kenny LC, Broadhurst DI, Dunn W et al. Robust Early pregnancy prediction of later preeclampsia using metabolomic biomarkers. Hypertension 56(4), 741-749 (2010).
8. Wang TJ, Larson MG, Vasan RS et al. Metabolite profiles and the risk of developing diabetes. Nature Med. 17(4), 448-453 (2011).
9. Sreekumar A, Poisson LM, Rajendiran TM et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457(7231), 910-914 (2009).
10. Yin P, Wan D, Zhao C et al. A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RPLC and HILIC coupled with mass spectrometry. Mol. BioSyst. 5(8), 868-876 (2009).
11. Myint KT, Uehara T, Aoshima K, Oda Y. Polar anionic metabolome analysis by nano-LC-MS with a metal chelating agent. Anal. Chem. 81(18), 7766-7772 (2009).
12. Uehara T, Yokoi A, Aoshima K et al. Quantitative phosphorus metabolomics using nanoflow liquid chromatography-tandem mass spectrometry and culture-derived comprehensive global internal standards. Anal. Chem. 81(10), 3836-3842 (2009).
13. Boernsen KO, Gatzek S, Imbert G. Controlled protein precipitation in combination with chip-based nanospray infusion mass spectrometry. An approach for metabolomics profiling of plasma. Anal. Chem. 77(22), 7255-7264 (2005). (Pubitemid 41681391)
14. Wishart DS, Knox C, Guo AC et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 37(Database issue), D603-D610 (2009).
15. Wishart DS, Tzur D, Knox C et al. HMDB: the human metabolome database. Nucleic Acids Res. 35(Database issue), D521-D526 (2007 (Pubitemid 46056263)
16. Psychogios N, Hau DD, Peng J et al. The human serum metabolome. PLoS ONE 6(2), e16957 (2011
17. Quehenberger O, Armando AM, Brown AH et al. Lipidomics reveals a remarkable diversity of lipids in human plasma. J. Lipid Res. 51(11), 3299-3305 (2010).
18. Zelena E, Dunn WB, Broadhurst D et al. Development of a robust and repeatable UPLC-MS method for the long-term metabolomic study of human serum. Anal. Chem. 81(4), 1357-1364 (2009
19. Michopoulos F, Lai L, Gika H, Theodoridis G, Wilson I. UPLC-MS-based analysis of human plasma for metabonomics using solvent precipitation or solid phase extraction. J. Proteome Res. 8(4), 2114-2121 (2009).
20. Crews B, Wikoff WR, Patti GJ et al. Variability analysis of human plasma and cerebral spinal fluid reveals statistical significance of changes in mass spectrometry-based metabolomics data. Anal. Chem. 81(20), 8538-8544 (2009).
21. Minami Y, Kasukawa T, Kakazu Y et al. Measurement of internal body time by blood metabolomics. Proc.Natl Acad. Sci. USA 106(24), 9890-9895 (2009).
22. Rai AJ, Gelfand CA, Haywood BC et al. HUPO plasma proteome project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 5(13), 3262-3277 (2005). (Pubitemid 41192034)
23. Denery JR, Nunes AAK, Hixon MS, Dickerson TJ, Janda KD. Metabolomics-based discovery of diagnostic biomarkers for onchocerciasis. PLoS Negl. Trop. Dis. 4(10), e834 (2010).
24. Lewis GD, Farrell L, Wood MJ et al. Metabolic signatures of exercise in human plasma. Sci. Transl. Med. 2(33), 33-37 (2010).
25. Ciborowski M, Javier Ruprez F, Martínez Alczar MP et al. Metabolomic approach with LC-MS reveals significant effect of pressure on diver's plasma. J. Proteome Res. 9(8), 4131-4137 (2010).
26. Loftus N, Miseki K, Iida J et al. Profiling and biomarker identification in plasma from different Zucker rat strains via high mass accuracy multistage mass spectrometric analysis using liquid chromatography-mass spectrometry with a quadrupole ion trap time of flight mass spectrometer. Rapid Commun. Mass Spectrom. 22(16), 2547-2554 (2008).
27. Williams R, Lenz EM, Wilson AJ et al. A multi-analytical platform approach to the metabonomic analysis of plasma from normal and Zucker (fa/fa) obese rats. Mol. Biosyst. 2(3-4), 174-183 (2006). (Pubitemid 43373976)
28. Serkova NJ, Zhang Y, Coatney JL et al. Early detection of graft failure using the blood metabolic profile of a liver recipient. Transplantation 83(4), 517-521 (2007). (Pubitemid 46667858)
29. van Ginneken V, Verhey E, Poelmann R et al. Metabolomics (liver and blood profiling) in a mouse model in response to fasting: a study of hepatic steatosis. Biochim. Biophys. Acta 1771(10), 1263-1270 (2007). (Pubitemid 47500220)
30. Bruce S, Jonsson P, Antti H et al. Evaluation of a protocol for metabolic profiling studies on human blood plasma by combined ultra-performance liquid chromatography- mass spectrometry: from extraction to data analysis. Anal. Biochem. 372(2), 237-249 (2008). (Pubitemid 350116776)
31. Bruce SJ, Breton I, Decombaz J et al. A plasma global metabolic profiling approach applied to an exercise study monitoring the effects of glucose, galactose and fructose drinks during post-exercise recovery. J. Chromatogr. B 878(29), 3015-3023 (2010).
32. Bruce SJ, Tavazzi I, Parisod V et al. Investigation of human blood plasma sample preparation for performing metabolomics using ultrahigh performance liquid chromatography-mass spectrometry. Anal. Chem. 81(9), 3285-3296 (2009
33. Michopoulos F, Edge AM, Theodoridis G, Wilson ID. Application of turbulent flow chromatography to the metabonomic analysis of human plasma: comparison with protein precipitation. J. Sep. Sci. 33(10), 1472-1479 (2010).
34. Lawton KA, Berger A, Mitchell M et al. Analysis of the adult human plasma metabolome. Pharmacogenomics 9(4), 383-397 (2008). (Pubitemid 351803924)
35. Steffens DC, Wei J, Krishnan KRR et al. Metabolomic differences in heart failure patients with and without major depression. J. Geriatr. Psychiatry Neurol. 23(2), 138-146 (2010).
36. Gao P, Lu C, Zhang F et al. Integrated GC-MS and LC-MS plasma metabonomics analysis of ankylosing spondylitis. Analyst 133(9), 1214-1220 (2008).
37. Lai L, Michopoulos F, Gika H et al. Methodological considerations in the development of HPLC-MS methods for the analysis of rodent plasma for metabonomic studies. Mol. Biosyst. 6(1), 108-120 (2010).
38. Sandra K, Pereira Ados S, Vanhoenacker G, David F, Sandra P. Comprehensive blood plasma lipidomics by liquid chromatography- quadrupole time-of-flight mass spectrometry. J. Chromatogr. A. 1217(25), 4087-4099 (2010).
39. Denery JR, Nunes AAK, Dickerson TJ. Characterization of differences between blood sample matrices in untargeted metabolomics. Anal. Chem. 83(3), 1040-1047 (2011).
40. Want EJ, Coen M, Masson P et al. Ultra performance liquid chromatography-mass spectrometry profiling of bile acid metabolites in biofluids: application to experimental toxicology studies. Anal. Chem. 82(12), 5282-5289 (2010).
41. Dettmer K, Almstetter MF, Appel IJ et al. Comparison of serum versus plasma collection in gas chromatography-mass spectrometry-based metabolomics. Electrophoresis 31(14), 2365-2373 (2010).
42. Dunn WB, Broadhurst D, Brown M et al. Metabolic profiling of serum using ultra performance liquid chromatography and the LTQ-orbitrap mass spectrometry system. J. Chromatogr. B 871(2), 288-298 (2008).
43. Lin L, Yu Q, Yan X et al. Direct infusion mass spectrometry or liquid chromatography mass spectrometry for human metabonomics? A serum metabonomic study of kidney cancer. Analyst 135(11), 2970-2978 (2010).
44. Bijlsma S, Bobeldijk I, Verheij ER et al. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal. Chem. 78(2), 567-574 (2006). (Pubitemid 43100391)
45. Michopoulos F, Theodoridis G, Smith CJ, Wilson ID. Metabolite Profiles from dried biofluid spots for metabonomic studies using UPLC combined with oaTOF-MS. J. Proteome Res. 9(6), 3328-3334 (2010).
46. Liu L, Aa J, Wang G et al. Differences in metabolite profile between blood plasma and serum. Anal. Biochem. 406(2), 105-112 (2010).
47. Want EJ, O'Maille G, Smith CA et al. Solvent-dependent metabolite distribution, clustering and protein extraction for serum profiling with mass spectrometry. Anal. Chem. 78 (Pubitemid 43228581)
48. Roux A, Lison D, Junot C, Heilier J-F. Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: a review. Clinical Biochem. 44(1), 119-135 (2011).
49. Sana TR, Waddell K, Fischer SM. A sample extraction and chromatographic strategy for increasing LC-MS detection coverage of the erythrocyte metabolome. J. Chromatogr. B 871(2), 314-321 (2008
50. Guilhaumou R, Lacarelle B, Sampol- Manos E. A rapid, simple and sensitive liquid chromatography-tandem mass spectrometry method for routine clinical monitoring of tacrolimus with the Waters Masstrak immmunosuppressant kit. Methods Find. Exp. Clin. Pharmacol. 32(10), 737-743 (2010).
51. Koster RA, Dijkers ECF, Uges DRA. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus and sirolimus in whole blood. Ther. Drug Monit. 31(1), 116-125 (2009).
52. Dwivedi P, Schultz AJ, Hill H. Metabolic profiling of human blood by high-resolution ion mobility-mass spectrometry (IM-MS). Intern. J. Mass Spectrom. 298(1-3), 78-90 (2010).
53. Van Berkel GJ, Kertesz V. Application of a liquid extraction based sealing surface sampling probe for mass spectrometric analysis of dried blood spots and mouse whole-body thin tissue sections. Anal. Chem. 81 (21), 9146-9152 (2009).
54. Spooner N, Lad R, Barfield M. Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method. Anal. Chem. 81(4), 1557-1563 (2009).
55. Zhang Y, A J, Wang G et al. Organic solvent extraction and metabonomic profiling of the metabolites in erythrocytes. J. Chromatogr. B 877(18-19), 1751-1757 (2009).
56. Gika HG, Theodoridis GA, Earll M et al. Does the mass spectrometer define the marker? A comparison of global metabolite profiling data generated simultaneously via UPLC-MS on two different mass spectrometers. Anal. Chem. 82(19), 8226-8234 (2010
57. HMDB Serum Metabolome. www.serummetabolome.ca
58. LipidMaps: Nature. www.lipidmaps.org
59. The HUSERMET project. www.husermet.org